Logo

ABL

Abacus Global Management, Inc.

ABL

Abacus Global Management, Inc. • NASDAQ
$6.63 ▲ 1.38% (+0.09)
Market Cap $648.10 M
52w High $9.61
52w Low $4.60
Dividend Yield 0.20%
P/E 132.6
Volume 287.94K
Outstanding Shares 97.75M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $62.975M ▲ $32.906M ▲ $7.075M ▼ 11.235% ▼ $0.07 ▼ $25.907M ▼
Q2-2025 $56.225M ▲ $27.65M ▲ $17.584M ▲ 31.274% ▲ $0.19 ▲ $35.617M ▲
Q1-2025 $44.139M ▲ $16.004M ▼ $4.64M ▲ 10.511% ▲ $0.048 ▲ $22.11M ▲
Q4-2024 $33.212M ▲ $46.255M ▲ $-18.257M ▼ -54.972% ▼ $-0.22 ▼ $-7.612M ▼
Q3-2024 $28.148M $19.111M $-5.125M -18.207% $-0.069 $428.414K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $86.419M ▲ $918.938M ▲ $479.344M ▲ $439.594M ▲
Q2-2025 $74.837M ▲ $848.358M ▼ $426.825M ▲ $421.604M ▼
Q1-2025 $43.762M ▼ $856.509M ▼ $420.93M ▼ $435.677M ▲
Q4-2024 $131.944M ▲ $874.165M ▲ $450.87M ▲ $424.153M ▲
Q3-2024 $22.429M $477.309M $219.37M $258.031M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $7.075M ▼ $-32.752M ▼ $-235.803K ▲ $44.57M ▲ $11.582M ▼ $-32.924M ▼
Q2-2025 $17.611M ▲ $76.102M ▲ $-10.004M ▼ $-35.023M ▼ $31.075M ▲ $75.694M ▲
Q1-2025 $4.64M ▲ $-61.591M ▲ $-3.739M ▲ $-22.852M ▼ $-88.183M ▼ $-61.815M ▲
Q4-2024 $-19.01M ▼ $-91.983M ▼ $-3.788M ▼ $208.306M ▲ $112.535M ▲ $-92.093M ▼
Q3-2024 $-5.447M $-52.285M $-451.053K $-19.178M $-71.914M $-52.528M

Revenue by Products

Product Q1-2025Q2-2025
Asset Management
Asset Management
 $10.00M ▲$10.00M ▲
Origination
Origination
 $0 ▲$0 ▲
Technology Service
Technology Service
 $0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has grown steadily since listing, moving from a tiny base to a more meaningful level, which shows the business is gaining commercial traction. Profitability, however, is uneven: the company moved from early profits to a recent loss, suggesting higher operating costs, integration spending, or investments in growth are weighing on the bottom line. Margins looked promising in the middle of the period but have recently compressed, which is common for a company scaling up and building new business lines. Overall, the income statement tells a story of rapid growth with still‑unproven, volatile earnings quality.

Balance Sheet

Balance Sheet The balance sheet has expanded quickly, with total assets, cash, debt, and equity all rising over the last few years. This points to a company aggressively building its platform, likely through acquiring policies, businesses, and technology capabilities. The growth in equity is a positive sign of capital support, but the increase in debt means leverage is now a more important risk factor to monitor. In short, Abacus looks better capitalized than before, but its growth is being partly financed with borrowing, which raises sensitivity to execution missteps and interest costs.

Cash Flow

Cash Flow Cash generation is a weak spot at this stage. The company briefly produced positive operating cash flow, but the last two years have swung back to meaningful cash outflows, indicating that growth and policy investments are consuming cash faster than the core business is producing it. With little in the way of traditional capital spending, the strain appears tied mainly to working capital and the nature of its longevity‑based assets rather than factories or equipment. This pattern is typical for a developing specialty finance platform but increases reliance on external funding and makes consistent cash conversion a key future test.

Competitive Edge

Competitive Edge Abacus operates in a specialized corner of financial services focused on life settlements and longevity‑linked assets, which already narrows its competitive field. Its vertically integrated model—originating, managing, and packaging its own policy assets—gives it more control over the value chain than many peers. The long‑standing, proprietary health and longevity datasets and the ABL Tech platform create meaningful barriers to entry, since accurate pricing and risk management in this space are hard to replicate. At the same time, the niche nature of the market, regulatory complexity, and the company’s relatively young public track record mean its competitive strength still needs to be proven at larger scale and through multiple economic cycles.

Innovation and R&D

Innovation and R&D Innovation at Abacus is centered on data, analytics, and product design rather than classic lab‑style R&D. The firm’s main edge is its proprietary longevity data and actuarial models, which underpin services like real‑time mortality verification and customized, lifespan‑based financial planning. It is extending these capabilities across multiple business lines—asset management, wealth management, and technology services—while also experimenting with securitized life insurance structures and potentially lifespan‑based retirement products. The opportunity is significant if these tools scale across pensions, institutions, and advisors, but success will depend on continually improving the models, navigating regulation, and demonstrating reliability to conservative institutional buyers.

Summary

Abacus Global Management is evolving from a niche life‑settlement operator into a broader, technology‑enabled longevity asset manager. The company shows strong top‑line momentum and a rapidly expanding balance sheet, but profits and cash flows are still inconsistent, reflecting early‑stage growth and substantial investment. Its competitive story rests on proprietary data, a vertically integrated structure, and differentiated, lifespan‑based products that are hard for generalist financial firms to copy. Key uncertainties revolve around sustaining growth without overextending leverage, turning innovative structures into steady fee income, and proving that its models hold up through stress and over time. Overall, Abacus looks like a fast‑growing but still maturing platform whose future will hinge on execution quality and risk management as much as on its technology edge.

NEWS

November 25, 2025 · 4:05 PM UTC

Abacus Global Management Announces Timing of Inaugural Dividend Distribution

Read more

November 6, 2025 · 4:06 PM UTC

Abacus Global Management Enhances Shareholder Returns with Annual Dividend and $10 Million Share Repurchase Program

Read more

October 23, 2025 · 8:00 AM UTC

Abacus Sells $50 Million of Securitized Life Insurance Assets to Institutional Investors

Read more

October 2, 2025 · 8:30 AM UTC

Alliance Entertainment Announces New 5-Year $120 Million Credit Facility with Bank of America

Read more

September 25, 2025 · 5:28 PM UTC

ABACUS (ABL) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Abacus Global Management, Inc. on Behalf of Abacus Stockholders and Encourages Investors to Contact the Firm

Read more